Co-Authors
This is a "connection" page, showing publications co-authored by Chantal Reusken and Johan Reimerink.
Connection Strength
1.159
-
Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories. J Clin Microbiol. 2021 08 18; 59(9):e0076721.
Score: 0.241
-
Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach. Emerg Microbes Infect. 2020 Dec; 9(1):1965-1973.
Score: 0.229
-
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT). Emerg Microbes Infect. 2020 Dec; 9(1):2394-2403.
Score: 0.229
-
Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections. J Infect Dis. 2020 09 14; 222(8):1265-1269.
Score: 0.226
-
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data. Euro Surveill. 2021 07; 26(27).
Score: 0.060
-
Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors. Clin Transl Immunology. 2021; 10(5):e1285.
Score: 0.059
-
Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort. Diagn Microbiol Infect Dis. 2021 Oct; 101(2):115392.
Score: 0.059
-
Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands. Nat Commun. 2020 11 12; 11(1):5744.
Score: 0.057